Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Stepanov

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
Alzheimer'S Research & Therapy|December 13, 2017
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brainsLaetitia Lemoine, Per-Göran Gillberg, Marie Svedberg, et al.
The International Journal of Neuropsychopharmacology|March 20, 2016
Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628Katarina Varnäs, Sjoerd J Finnema, Vladimir Stepanov, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2018
Dual tracer tau PET imaging reveals different molecular targets for <sup>11</sup>C-THK5351 and <sup>11</sup>C-PBB3 in the Alzheimer brainKonstantinos Chiotis, Per Stenkrona, Ove Almkvist, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2014
(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET StudySjoerd J Finnema, Vladimir Stepanov, Ryuji Nakao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2020
PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [<sup>18</sup>F]PF-06684511Ryosuke Arakawa, Akihiro Takano, Per Stenkrona, et al.
The International Journal of Neuropsychopharmacology|June 23, 2026
Viloxazine occupies the 5-HT2C receptor in the macaca fascicularis brain in vivo: A [11C]CIMBI-36 positron emission tomography studyJennie Garcia-Olivares, Brittney Yegla, Khanum Ridler, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Development of <sup>18</sup>F/<sup>11</sup>C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET RadioligandsSangram Nag, Vladimir Stepanov, Akihiro Takano, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brainSjoerd J Finnema, Zoë A Hughes, Merja Haaparanta-Solin, et al.
Journal of Medicinal Chemistry|August 5, 2021
[<sup>11</sup>C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological ProteinsLongbin Liu, Peter D Johnson, Michael E Prime, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
Alzheimer'S Research & Therapy|December 13, 2017
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brainsLaetitia Lemoine, Per-Göran Gillberg, Marie Svedberg, et al.
The International Journal of Neuropsychopharmacology|March 20, 2016
Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628Katarina Varnäs, Sjoerd J Finnema, Vladimir Stepanov, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2018
Dual tracer tau PET imaging reveals different molecular targets for <sup>11</sup>C-THK5351 and <sup>11</sup>C-PBB3 in the Alzheimer brainKonstantinos Chiotis, Per Stenkrona, Ove Almkvist, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2014
(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET StudySjoerd J Finnema, Vladimir Stepanov, Ryuji Nakao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2020
PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [<sup>18</sup>F]PF-06684511Ryosuke Arakawa, Akihiro Takano, Per Stenkrona, et al.
The International Journal of Neuropsychopharmacology|June 23, 2026
Viloxazine occupies the 5-HT2C receptor in the macaca fascicularis brain in vivo: A [11C]CIMBI-36 positron emission tomography studyJennie Garcia-Olivares, Brittney Yegla, Khanum Ridler, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Development of <sup>18</sup>F/<sup>11</sup>C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET RadioligandsSangram Nag, Vladimir Stepanov, Akihiro Takano, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brainSjoerd J Finnema, Zoë A Hughes, Merja Haaparanta-Solin, et al.
Journal of Medicinal Chemistry|August 5, 2021
[<sup>11</sup>C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological ProteinsLongbin Liu, Peter D Johnson, Michael E Prime, et al.
Pageof 5